TG Therapeutics Inc (NASDAQ:TGTX)

Data as of 10:11am ET
 -0.235 / -1.56%
Today’s Change
Today|||52-Week Range

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Operating ActivitiesNet Income / Starting Line-889.1K-26.2M-20.5M--
Total Other Cash Flow390.6K20.4M5.5M--
Funds From Operations-498.5K-5.8M-15.0M--
Funds From/For Other Operating Expenses-411.9K-644.0K-4.2M--
Net Cash Flow - Operating Activities-86.6K-5.2M-10.8M--
InvestingFixed Asset Disposal10.4K0.00----
Net Cash Flow Investing10.4K-1.4K-4.9M--
FinancingShort Term Borrowings----------
Long Term Borrowings----------
Long Term Debt Reduction----------
Net Proceeds Stock Sale----------
Common Preferred Redeemed----------
Common Dividends----------
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing----------
Other Uses - Financing----------
Net Cash Flow - Financing9.8M11.9M39.8M--
Exchange RateEffect of Exchange Rate on Cash----0.00----
Net Change In Cash9.7M6.7M24.0M--

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.